These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 17043874)
1. Histological response to injected dextranomer-based implant in a rat model. Alkan M; Ciftci AO; Talim B; Senocak ME; Caglar M; Buyukpamukcu N Pediatr Surg Int; 2007 Feb; 23(2):183-7. PubMed ID: 17043874 [TBL] [Abstract][Full Text] [Related]
2. Histological response to injected gluteraldehyde cross-linked bovine collagen based implant in a rat model. Alkan M; Talim B; Ciftci AO; Senocak ME; Caglar M; Büyükpamukçu N BMC Urol; 2006 Feb; 6():3. PubMed ID: 16503996 [TBL] [Abstract][Full Text] [Related]
7. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [TBL] [Abstract][Full Text] [Related]
8. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062 [TBL] [Abstract][Full Text] [Related]
10. Comparison of histopathological characteristics of polyacrylate polyalcohol copolymer with dextranomer/hyaluronic acid after injection beneath the bladder mucosa layer: a rabbit model. Kajbafzadeh AM; Sabetkish S; Khorramirouz R; Sabetkish N Int Urol Nephrol; 2017 May; 49(5):747-752. PubMed ID: 28210914 [TBL] [Abstract][Full Text] [Related]
11. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer. Palmer LS J Urol; 2008 Mar; 179(3):1118-20; discussion 1121. PubMed ID: 18206944 [TBL] [Abstract][Full Text] [Related]
12. Giant cell reaction with phagocytosis adjacent to dextranomer-hyaluronic acid (Deflux) implant: possible reason for Deflux failure. Broderick K; Thompson JH; Khan AR; Greenfield SP J Pediatr Urol; 2008 Aug; 4(4):319-21. PubMed ID: 18644540 [No Abstract] [Full Text] [Related]
13. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter? Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239 [TBL] [Abstract][Full Text] [Related]
14. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents. Stredele RJ; Dietz HG; Stehr M J Pediatr Urol; 2013 Feb; 9(1):71-6. PubMed ID: 22212178 [TBL] [Abstract][Full Text] [Related]
15. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems. Hunziker M; Mohanan N; Puri P J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268 [TBL] [Abstract][Full Text] [Related]
16. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Moore K; Bolduc S J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269 [TBL] [Abstract][Full Text] [Related]
17. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. Puri P; Kutasy B; Colhoun E; Hunziker M J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657 [TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management. Benoit RM; Peele PB; Docimo SG J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694 [TBL] [Abstract][Full Text] [Related]